Severe hypoglycaemia, cardiovascular outcomes and death: Experience from the 'Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results' (LEADER) trial

被引：0
|
作者：
Bain, S. [1 ]
Zinman, B. [2 ]
Marso, S. P. [3 ]
Christiansen, E. [4 ]
Calanna, S. [4 ]
Rasmussen, S. [4 ]
Buse, J. B. [5 ]
机构：
[1] Univ Swansea, Sch Med, Swansea, W Glam, Wales
[2] Univ Toronto, Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada
[3] Res Med Ctr, Kansas City, MO USA
[4] Novo Nordisk AS, Soborg, Denmark
[5] Univ N Carolina, Sch Med, Chapel Hill, NC USA
来源：
DIABETIC MEDICINE | 2018年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A17
引用
收藏
页码：11 / 11
页数：1
相关论文
共 50 条
  • [21] Liraglutide reduces major cardiovascular events in patients with chronic kidney disease: results from the LEADER trial
    Poulter, N.
    Mann, J.
    Fonseca, V.
    Mosenzon, O.
    Raz, I.
    Frimer-Larsen, H.
    von Scholten, B.
    Idorn, T.
    DIABETOLOGIA, 2018, 61 : S38 - S39
  • [22] Do Some Glucagon-Like-Peptide-1 Receptor Agonists (GLP-1 RA) Reduce Macrovascular Complications of Type 2 Diabetes Mellitus? A Commentary on the Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER) Trial
    Athyros, Vasilios G.
    Katsiki, Niki
    Tentolouris, Nikolaos
    CURRENT VASCULAR PHARMACOLOGY, 2016, 14 (05) : 469 - 473
  • [23] Effect of liraglutide on cardiovascular outcomes in patients with or without prior heart failure history in LEADER
    Saevereid, H. A.
    Husain, M.
    Bain, S. C.
    Mann, J. F. E.
    Nauck, M. A.
    Poulter, N.
    Goldman, B.
    Thomsen, A. B.
    Marso, S.
    DIABETOLOGIA, 2018, 61 : S564 - S565
  • [24] Exploring the impact of liraglutide on diabetic foot ulcers on subjects with type 2 diabetes and increased risk of cardiovascular events: results from the LEADER trial
    Dhatariya, K.
    Bain, S. C.
    Pratley, R. E.
    Buse, J. B.
    Simpson, R.
    Tarnow, L.
    Stellfeld, M.
    Kaltoft, M. S.
    Tornoe, K.
    DIABETOLOGIA, 2017, 60 : S465 - S465
  • [25] Results from Cardiovascular Outcome Trials in Diabetes
    Munoz Torres, Manuel
    Munoz Garach, Araceli
    ENDOCRINOLOGIA Y NUTRICION, 2016, 63 (07): : 317 - 319
  • [26] Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease Results From the LEADER Trial
    Mann, Johannes F. E.
    Fonseca, Vivian
    Mosenzon, Ofri
    Raz, Itamar
    Goldman, Bryan
    Idorn, Thomas
    von Scholten, Bernt Johan
    Poulter, Neil R.
    CIRCULATION, 2018, 138 (25) : 2908 - 2918
  • [27] Liraglutide reduces cardiovascular events and mortality in type 2 diabetes independent of LDL cholesterol and statin use: results of the LEADER trial
    Leiter, L. A.
    Verma, S.
    Mazer, C.
    Bain, S. C.
    Buse, J.
    Marso, S.
    Nauck, M. A.
    Zinman, B.
    Bosch-Traberg, H.
    Frimer-Larsen, H.
    Michelsen, M. M.
    Bhatt, D. L.
    DIABETOLOGIA, 2018, 61 : S356 - S357
  • [28] Liraglutide reduces cardiovascular events and mortality in type 2 diabetes independent of LDL cholesterol and statin use: results of the LEADER trial
    Verma, S.
    Leiter, L. A.
    Mazer, C. D.
    Bain, S. C.
    Buse, J.
    Marso, S.
    Nauck, M.
    Zinman, B.
    Bosch-Traberg, H.
    Frimer-Larsen, H.
    Michelsen, M. M.
    Bhatt, D. L.
    EUROPEAN HEART JOURNAL, 2018, 39 : 598 - 598
  • [29] The Impact of Liraglutide on Diabetes-Related Foot Ulceration and Associated Complications in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events: Results From the LEADER Trial
    Dhatariya, Ketan
    Bain, Stephen C.
    Buse, John B.
    Simpson, Richard
    Tarnow, Lise
    Kaltoft, Margit Staum
    Stellfeld, Michael
    Tornoe, Karen
    Pratley, Richard E.
    DIABETES CARE, 2018, 41 (10) : 2229 - 2235
  • [30] Risk of major cardiovascular events in patients with type 2 diabetes with and without prior cardiovascular events: results from the LEADER trial
    Poulter, N. R.
    Bain, S. C.
    Buse, J. B.
    Monk-Hansen, T.
    Nauck, M.
    Rasmussen, S.
    Pratley, R.
    Zinman, B.
    Orsted, D.
    Marso, S. P.
    EUROPEAN HEART JOURNAL, 2017, 38 : 819 - 819
12345